Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
166.245 USD
0.96%
Market Closed
Updated:
Apr 19, 2024
Abbvie Inc
Tax Provision
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Tax Provision Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Tax Provision
$-1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Tax Provision
$-1.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Tax Provision
$-1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-20%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Tax Provision
$-760.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Tax Provision
$-245.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
2%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Tax Provision
$-11.2m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Tax Provision?
Tax Provision
-1.4B
USD
-1.4B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Tax Provision amounts to -1.4B USD.
What is Abbvie Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-1%
-1%
Over the last year, the Tax Provision growth was 16%.
You don't have any saved screeners yet
